These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
973 related articles for article (PubMed ID: 27255713)
1. Drug Treatment of Venous Thromboembolism in the Elderly. Boey JP; Gallus A Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713 [TBL] [Abstract][Full Text] [Related]
2. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments. Eek AK; Øie E; Granas AG Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366 [TBL] [Abstract][Full Text] [Related]
3. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know. Steed MB; Swanson MT Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905 [TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. Vinogradova Y; Coupland C; Hill T; Hippisley-Cox J BMJ; 2018 Jul; 362():k2505. PubMed ID: 29973392 [TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study. Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116 [TBL] [Abstract][Full Text] [Related]
10. Direct oral anticoagulants: An update. Franco Moreno AI; Martín Díaz RM; García Navarro MJ Med Clin (Barc); 2018 Sep; 151(5):198-206. PubMed ID: 29295790 [TBL] [Abstract][Full Text] [Related]
11. Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin. Chun KH; Lee H; Hong JH; Seo KD J Am Heart Assoc; 2024 Aug; 13(15):e034698. PubMed ID: 39101509 [TBL] [Abstract][Full Text] [Related]
13. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation. Fanikos J; Burnett AE; Mahan CE; Dobesh PP Am J Med; 2017 Sep; 130(9):1015-1023. PubMed ID: 28502818 [TBL] [Abstract][Full Text] [Related]
14. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants. Weitz JI; Jaffer IH Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
16. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements. Pasciolla S; Zizza LF; Le T; Wright K Clin Drug Investig; 2020 Sep; 40(9):839-845. PubMed ID: 32607688 [TBL] [Abstract][Full Text] [Related]
18. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin . Adachi T; Hoshino H; Takagi M; Fujioka S; Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486 [TBL] [Abstract][Full Text] [Related]
19. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Beyer-Westendorf J; Ageno W Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150 [TBL] [Abstract][Full Text] [Related]
20. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]